Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas

Virchows Archiv

Volumn 460, Issue 6, 2012, Pages 629-636

  De Vries, Maurits ^a   Hogendoorn, Pancras C W ^a   De Bruyn, Inge Briaire ^a   Malessy, Martijn J A ^a   Van Der Mey, Andel G L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Neuropathology; Tumor biology; Vestibular schwannoma

Indexed keywords

ACOUSTIC NEURINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLOOD VESSEL; CELL PROLIFERATION; FEMALE; GROWTH RATE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; FEMALE; HEMOSIDERIN; HUMANS; INFLAMMATION; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NEUROMA, ACOUSTIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84863982048     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1236-9     Document Type: Article

References (38)

1. Szeremeta W, Monsell EM, Rock JP, Caccamo DV (1995) Proliferation indices of vestibular schwannomas by Ki-67 and proliferating cell nuclear antigen. Am J Otol 16(5):616-619
2. Niemczyk K, Vaneecloo FM, Lecomte MH, Lejeune JP, Lemaitre L, Skarzynski H et al (2000) Correlation between Ki-67 index and some clinical aspects of acoustic neuromas (vestibular schwannomas). Otolaryngol Head Neck Surg 123(6):779-783
3. Davidson EJ, Morris LS, Scott IS, Rushbrook SM, Bird K, Laskey RA et al (2003) Minichromosome maintenance (Mcm) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasia. Br J Cancer 88(2):257-262 (Pubitemid 36255845)
4. Brenner RM, Slayden OD, Rodgers WH, Critchley HO, Carroll R, Nie XJ et al (2003) Immunocytochemical assessment of mitotic activity with an antibody to phosphorylated histone H3 in the macaque and human endometrium. Hum Reprod 18(6):1185-1193 (Pubitemid 36740562)
5. Takahashi H, Murai Y, Tsuneyama K, Nomoto K, Okada E, Fujita H et al (2006) Overexpression of phosphorylated histone H3 is an indicator of poor prognosis in gastric adenocarcinoma patients. Appl Immunohistochem Mol Morphol 14(3):296-302 (Pubitemid 44319055)
6. (1995) Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC. Otolaryngol Head Neck Surg 113 (3):179-180.
7. Bovee JV, van den Broek LJ, de Boer WI, Hogendoorn PC (1998) Expression of growth factors and their receptors in adamantinoma of long bones and the implication for its histogenesis. J Pathol 184 (1):24-30 (Pubitemid 28086149)
8. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M et al (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38(12):1564-1579 (Pubitemid 34876495)
9. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL (1995) Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 177(3):275-283
10. de Andrea CE, Wiweger MI, Bovee JV, Romeo S, Hogendoorn PC (2011) Peripheral chondrosarcoma progression is associated with increased type X collagen and vascularisation. Virchows Arch 460 (1):95-102
11. Koutsimpelas D, Stripf T, Heinrich UR, Mann WJ, Brieger J (2007) Expression of vascular endothelial growth factor and basic fibroblast growth factor in sporadic vestibular schwannomas correlates to growth characteristics. Otol Neurotol 28(8):1094-1099 (Pubitemid 350191085)
12. Bedavanija A, Brieger J, Lehr HA, Maurer J, Mann WJ (2003) Association of proliferative activity and size in acoustic neuroma: implications for timing of surgery. J Neurosurg 98(4):807-811 (Pubitemid 36396783)
13. Gomez-Brouchet A, Delisle MB, Cognard C, Bonafe A, Charlet JP, Deguine O et al (2001) Vestibular schwannomas: correlations between magnetic resonance imaging and histopathologic appearance. Otol Neurotol 22(1):79-86 (Pubitemid 32182857)
14. Jeng CM, Huang JS, Lee WY, Wang YC, Kung CH, Lau MK (1995) Magnetic resonance imaging of acoustic schwannomas. J Formos Med Assoc 194(8):487-493
15. Fundova P, Charabi S, Tos M, Thomsen J (2000) Cystic vestibular schwannoma: surgical outcome. J Laryngol Otol 114(12):935-939 (Pubitemid 32105505)
16. Jones SE, Baguley DM, Moffat DA (2007) Are facial nerve outcomes worse following surgery for cystic vestibular schwannoma? Skull Base 17(5):281-284 (Pubitemid 47577668)
17. Sinha S, Sharma BS (2008) Cystic acoustic neuromas: surgical outcome in a series of 58 patients. J Clin Neurosci 15(5):511-515
18. Charabi S, Mantoni M, Tos M, Thomsen J (1994) Cystic vestibular schwannomas: neuroimaging and growth rate. J Laryngol Otol 108 (5):375-379 (Pubitemid 24148412)
19. Park CK, Kim DC, Park SH, Kim JE, Paek SH, Kim DG et al (2006) Microhemorrhage, a possible mechanism for cyst formation in vestibular schwannomas. J Neurosurg 105(4):576-580
20. Stadlbauer A, Buchfelder M, Nimsky C, Saeger W, Salomonowitz E, Pinker K et al (2008) Proton magnetic resonance spectroscopy in pituitary macroadenomas: preliminary results. J Neurosurg 109 (2):306-312
21. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285(21):1182-1186
22. Charabi S, Simonsen K, Charabi B, Jacobsen GK, Moos T, Rygaard J et al (1996) Nerve growth factor receptor expression in heterotransplanted vestibular schwannoma in athymic nude mice. Acta Otolaryngol 116(1):59-63 (Pubitemid 26040040)
23. Charabi S (1997) Acoustic neuroma/vestibular schwannoma in vivo and in vitro growth models. A clinical and experimental study. Acta Otolaryngol Suppl 530:1-27
24. van Rijswijk CS, Kunz P, Hogendoorn PC, Taminiau AH, Doornbos J, Bloem JL (2002) Diffusion-weighted MRI in the characterization of soft-Tissue tumors. J Magn Reson Imaging 15(3):302-307 (Pubitemid 34195126)
25. Bonneville F, Savatovsky J, Chiras J (2007) Imaging of cerebellopontine angle lesions: an update. Part 2: intra-Axial lesions, skull base lesions that may invade the CPA region, and non-enhancing extra-Axial lesions. Eur Radiol 17(11):2908-2920 (Pubitemid 47603987)
26. Pedrosa I, Alsop DC, Rofsky NM (2009) Magnetic resonance imaging as a biomarker in renal cell carcinoma. Cancer 115(10 Suppl):2334-2345
27. Brieger J, Bedavanija A, Lehr HA, Maurer J, Mann WJ (2003) Expression of angiogenic growth factors in acoustic neurinoma. Acta Otolaryngol 123(9):1040-1045 (Pubitemid 38021519)
28. Labit-Bouvier C, Crebassa B, Bouvier C, Andrac-Meyer L, Magnan J, Charpin C (2000) Clinicopathologic growth factors in vestibular schwannomas: a morphological and immunohistochemical study of 69 tumours. Acta Otolaryngol 120(8):950-954 (Pubitemid 32738494)
29. Buddingh EP, Kuijjer ML, Duim RA, Burger H, Agelopoulos K, Myklebost O et al (2011) Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents. Clin Cancer Res 17(8):2110-2119
30. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30(7):1073-1081
31. Hsu HP, Shan YS, Lai MD, Lin PW (2010) Osteopontin-positive infiltrating tumor-Associated macrophages in bulky ampullary cancer predict survival. Cancer Biol Ther 10(2):144-154
32. Lin EY, Nguyen AV, Russell RG, Pollard JW (2001) Colonystimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193(6):727-740
33. Mantovani A, Romero P, Palucka AK, Marincola FM (2008) Tumour immunity: effector response to tumour and role of the microenvironment. Lancet 371(9614):771-783
34. Ojalvo LS, Whittaker CA, Condeelis JS, Pollard JW (2010) Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol 184(2):702-712
35. Qian B, Deng Y, Im JH, Muschel RJ, Zou Y, Li J et al (2009) A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One 4(8): e6562
36. Solinas G, Germano G, Mantovani A, Allavena P (2009) Tumorassociated macrophages (TAM) as major players of the cancerrelated inflammation. J Leukoc Biol 86(5):1065-1073
37. Allavena P, Signorelli M, Chieppa M, Erba E, Bianchi G, Marchesi F et al (2005) Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production. Cancer Res 65(7):2964-2971 (Pubitemid 40490102)
38. Mukhtar RA, Nseyo O, Campbell MJ, Esserman LJ (2011) Tumorassociated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn 11 (1):91-100